Literature DB >> 16481524

Structural features of lipopolysaccharide from Rickettsia typhi: the causative agent of endemic typhus.

Marcela Fodorova1, Pavol Vadovic, Ludovit Skultety, Katarina Slaba, Rudolf Toman.   

Abstract

Rickettsia typhi causes endemic typhus, a relatively mild, acute febrile illness characterized by headache and macular rash. It is maintained in rodents and transmitted to humans by flea Xenopsylla cheopis. R. typhi contains a lipopolysaccharide thought to display a noticeable antigenic activity. We examined its structural features and it appears that the O-specific chain of the R. typhi LPS is composed mainly of the alternating Glc and QuiNAc residues linked by 1-->4 bonds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16481524     DOI: 10.1196/annals.1355.041

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Activation of ASC Inflammasome Driven by Toll-Like Receptor 4 Contributes to Host Immunity against Rickettsial Infection.

Authors:  Claire Rumfield; Ilirjana Hyseni; Jere W McBride; David H Walker; Rong Fang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  Pattern Recognition Receptors in Innate Immunity to Obligate Intracellular Bacteria.

Authors:  James R Fisher; Zachary D Chroust; Florence Onyoni; Lynn Soong
Journal:  Zoonoses (Burlingt)       Date:  2021-10-25

3.  Liver Necrosis and Lethal Systemic Inflammation in a Murine Model of Rickettsia typhi Infection: Role of Neutrophils, Macrophages and NK Cells.

Authors:  Stefanie Papp; Kristin Moderzynski; Jessica Rauch; Liza Heine; Svenja Kuehl; Ulricke Richardt; Heidelinde Mueller; Bernhard Fleischer; Anke Osterloh
Journal:  PLoS Negl Trop Dis       Date:  2016-08-22

4.  Immunity against the Obligate Intracellular Bacterial Pathogen Rickettsia australis Requires a Functional Complement System.

Authors:  Sean P Riley; Abigail I Fish; Fabio Del Piero; Juan J Martinez
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.